Publications by authors named "Haijun Mu"

Claim this Profile
P
PRDM14 promoted NSCLC cell proliferation, migration and invasion via modulating H3K27me3-mediated PEBP1/Raf-1/MEK/ERK MAPK signaling.
He Shi, Yunfei Jiang, Haijun Mu, Guohua Liu, Xinyue Cheng

Genes Genomics· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing trends in lung cancer disease burden between China and Australia from 1990 to 2019 and its predictions.
Dan Zhao, Haijun Mu, Ping Yu, Chao Deng

Thorac Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of therapeutic targets and mechanisms of tumorigenesis in non-small cell lung cancer using multiple-microarray analysis.
Dan Zhao, Hai-Jun Mu, Hai Bing Shi, Hong Xia Bi, Yun Fei Jiang

Medicine (Baltimore)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tubeimoside-1 inhibits the proliferation and metastasis by promoting miR-126-5p expression in non-small cell lung cancer cells.
Hanbing Shi, Hongxia Bi, Xingyuan Sun, Haiying Dong, Yunfei Jiang, Haijun Mu

Oncol Lett· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway.
Hanbing Shi, Hongxia Bi, Xingyuan Sun, Haiying Dong, Yunfei Jiang, Haijun Mu

Mol Med Rep· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis